दिव्य-दूत

NMDC commissions Rs 5,427 crore Iron ore processing plant, slurry pipeline and pellet plant in Bastar, Chhattisgarh NMDC's CSR funding supports its infrastructure and continued operations. Aastha Gurukul is transforming lives in Dantewada. असम को 3,200 मेगावॉट की नई ऊर्जा, सीएम हिमंत बिस्वा सरमा ने रखी अदाणी पावर प्रोजेक्ट की नींव Training of Trainers Programme on Master Circulars and Vigilance Manual 2026 अदाणी पावर छोटे भंडार में हर्षोल्लास के साथ मनाया गया 80वाँ स्वतंत्रता दिवस प्रधानमंत्री के नेतृत्व में देश की सनातन संस्कृति को मिला नया गौरव >> मुख्यमंत्री साय विशेष ग्राम सभा में ग्रामवासियों को जनगणना के सम्बन्ध किया जा रहा है जागरुक न्यू एज मीडिया में दक्ष बनें जनसंपर्क अधिकारी >> रजत बंसल आयुक्त मुख्यमंत्री विष्णु देव साय से आईओसीएल के मुख्य महाप्रबंधक ने की सौजन्य मुलाकात मुख्यमंत्री विष्णु देव साय ने कचहरी चौक स्थित एसबीआई के नये भवन का किया शुभारंभ, आधुनिक बैंकिंग सुविधाओं से मिलेगा लाभ “Dr. B.R. Ambedkar reminded us that ‘liberty, equality and fraternity’ are not separate ideals” >>, Amitav Mukherjee, CMD, NMDC AI आधारित शिक्षा से छत्तीसगढ़ को ज्ञान, कौशल और नवाचार का अग्रणी केंद्र बनाना हमारा ध्येय है >>> मुख्यमंत्री विष्णु देव साय NMDC के डायरेक्टर फाइनेंस अनुराग कपिल ने पदभार संभाला। एएएचएल और ब्लिंकिट ने मुंबई एयरपोर्ट पर शुरू की भारत की पहली 'इन-टर्मिनल' क्विक कॉमर्स सेवा APSEZ Crosses 500 MillionTonnes Cargo Milestone, Reinforcing Its Role in India’s Growth Story प्रदेश की लाइफलाइन हुई सशक्त मुख्यमंत्री विष्णुदेव साय ने 370 नई एम्बुलेंस को दिखाई हरी झंडी आदिवासियों के उत्थान के लिए प्रतिबद्ध है हमारी सरकार >> मुख्यमंत्री विष्णु देव साय Rare Earth Elements Minerals are at the heart of energy security, defence, capability and efforts to build a truly self-reliant India >>> Amitava Mukherjee CMD, NMDC जिन्दल स्टील को ओडिशा में दो लौह अयस्क ब्लॉकों के लिए बोलीदाता घोषित मुख्यमंत्री विष्णु देव साय ने विधानसभा अध्यक्ष डॉ. रमन सिंह से की सौजन्य मुलाकात

National Webinar Organized by Faculty of Science, Department of Bio-technology of Kalinga University

Anil Choubey 22-08-2021 08:29:02


Raipur, //// Kalinga University, Raipur is a well-known University  in Central India that focuses on quality education and research. The University believes in holistic development of the students and thus facilitate the students to enhance and develop practical skills, techniques, or ideas which they can use in their work or their daily lives. To take this endeavour ahead, the Faculty of Science, Department of Biotechnology, Kalinga University organised a National Webinar on 21stAugust, 2021 on the topic “New Health Care Challenges in Post Covid Period”. The keynote speaker for the webinar was Dr. Manish Shrivastava, MBBS-DOMS, Director Varun Netralaya, Raipur, Chhattisgarh.

The webinar was marked by the eminent presence of Vice-Chancellorof the university- Dr. R. Shridhar, Director General- Dr. Byju John, Registrar- Dr. Sandeep Gandhi, Dean Student Welfare- Dr. Asha Ambhaikar, Dean Academic Affairs, Faculty members and students of the department and participants across the country.  The opening of ceremony done by Dr. Sushma Dubey. Keynote speaker Dr. Manish Shrivastava addressed the health issues of Covid-19 and shared new health care challenges. He also emphasized on the importance of dietary habits and practice of exercise to reduce the health risks along with following the Covid-19 precautions and guidelines. The deliberation of Dr. Manish Shrivastava received an overwhelming response with 211 participants as it was very informative and educative. The students were highly benefitted by the insights that he provided regarding the subject matter of the webinar.

Dr. Sushma Dubey, Head of the Department of Biotechnology was the convener of the webinar, Dr. VaraprasadKolla, Dean, Faculty of Science and Dr. Anju Meshram, Dr. Ramswaroop Saini, Mr. DilendraChandrakar, and Ms. NiraliBudhbhatti, were in the organizing committee of the same. At the end of the academically enriching event, vote of thanks was extended by Dr. Sushma Dubey.

Comments

Subscribe

Receive updates and latest news direct from our team. Simply enter your email below :

ADs